Regional Covid-19 Resources and On Reserve Stats by Region Below:
Black = New Cases, Green = Recovered, Red = Deaths, Blue – Hospitalized, Purple – ISC reported total –  Updated Daily
BC
14 458 158 8,632 8,804
AB
9 1,046 185 20,082 20,311
SK
0 495 129 16,186 16,343
MB
4 901 155 25,118 25,283
ON
81 365 80 21,111 21,459
QC
86 115 26 13,653 13,793
Atlantic
0 14 9 4,614 4,658
North60
10 326 56 19,406 19,499
 

After a 5-year fight to lower drug prices, Ottawa’s pledge quietly falls apart – CBC

What began with a promise to protect Canadians ended with a commitment to support pharmaceutical companies

May 12, 2022

The first clue was the timing — late afternoon before a long weekend.

It’s a classic move for governments to make controversial announcements when fewer people are paying attention.

So when an innocuous-sounding news release from Health Canada about “proceeding with amendments to the Patented Medicines Regulations” came out at 5 p.m. on April 14, the eve of the Easter holiday, there were few headlines.

But it was breaking news, because the Trudeau government was announcing the end of a five-year⁠ fight ⁠with the pharmaceutical industry over regulations to lower drug prices.

When the federal health minister explained almost a week later why his government was abandoning reforms that could have saved billions in drug costs, Jean-Yves Duclos cited the industry’s needs⁠ “for research, development and production capacity.”

So what began with a promise to protect Canadians ended with a commitment to support pharmaceutical companies.

Read more: https://www.cbc.ca/news/health/drug-prices-canada-regulations-1.6449265

NationTalk Partners & Sponsors Learn More